KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 87 filers reported holding KARUNA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | -23.3% | 138 | 0.0% | 0.00% | – |
| Q2 2023 | $30 | +20.0% | 138 | 0.0% | 0.00% | – |
| Q1 2023 | $25 | -7.4% | 138 | 0.0% | 0.00% | – |
| Q4 2022 | $27 | -99.9% | 138 | +13.1% | 0.00% | – |
| Q3 2022 | $27,000 | +92.9% | 122 | +9.9% | 0.00% | – |
| Q2 2022 | $14,000 | +27.3% | 111 | +29.1% | 0.00% | – |
| Q1 2022 | $11,000 | 0.0% | 86 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -8.3% | 86 | -14.9% | 0.00% | – |
| Q3 2021 | $12,000 | +100.0% | 101 | +87.0% | 0.00% | – |
| Q2 2021 | $6,000 | 0.0% | 54 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | +20.0% | 54 | +8.0% | 0.00% | – |
| Q4 2020 | $5,000 | -54.5% | 50 | -66.0% | 0.00% | – |
| Q3 2020 | $11,000 | 0.0% | 147 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | 0.0% | 147 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | 0.0% | 147 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |